Doxycycline postexposure prophylaxis (doxyPEP) in a patient with antiphospholipid syndrome receiving warfarin: balancing STI prevention and anticoagulation safety.

Freer G, Phillips N, Fadzillah H, Wallis E

Open source

DOI
10.1136/sextrans-2026-057143
Published
2026 Sep 25
Container
Sexually transmitted infections
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/sextrans-2026-057143,
  title = {Doxycycline postexposure prophylaxis (doxyPEP) in a patient with antiphospholipid syndrome receiving warfarin: balancing STI prevention and anticoagulation safety.},
  author = {Freer G and Phillips N and Fadzillah H and Wallis E},
  year = {2026},
  journal = {Sexually transmitted infections},
  doi = {10.1136/sextrans-2026-057143},
  url = {https://doi.org/10.1136/sextrans-2026-057143}
}

RIS

TY  - JOUR
TI  - Doxycycline postexposure prophylaxis (doxyPEP) in a patient with antiphospholipid syndrome receiving warfarin: balancing STI prevention and anticoagulation safety.
AU  - Freer G
AU  - Phillips N
AU  - Fadzillah H
AU  - Wallis E
PY  - 2026
JO  - Sexually transmitted infections
DO  - 10.1136/sextrans-2026-057143
UR  - https://doi.org/10.1136/sextrans-2026-057143
ER  - 

APA

G, F., N, P., H, F., & E, W. (2026). Doxycycline postexposure prophylaxis (doxyPEP) in a patient with antiphospholipid syndrome receiving warfarin: balancing STI prevention and anticoagulation safety.. Sexually transmitted infections. https://doi.org/10.1136/sextrans-2026-057143

Source records